Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-31 2025-03-31 2 true false 2024-05-10 No description of principal activity false The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 15712918 2024-05-09 15712918 2024-05-10 2025-03-31 15712918 2023-05-10 2024-05-09 15712918 2025-03-31 15712918 c:Director1 2024-05-10 2025-03-31 15712918 d:MotorVehicles 2024-05-10 2025-03-31 15712918 d:MotorVehicles 2025-03-31 15712918 d:MotorVehicles d:OwnedOrFreeholdAssets 2024-05-10 2025-03-31 15712918 d:OfficeEquipment 2024-05-10 2025-03-31 15712918 d:OfficeEquipment 2025-03-31 15712918 d:OfficeEquipment d:OwnedOrFreeholdAssets 2024-05-10 2025-03-31 15712918 d:ComputerEquipment 2024-05-10 2025-03-31 15712918 d:ComputerEquipment 2025-03-31 15712918 d:ComputerEquipment d:OwnedOrFreeholdAssets 2024-05-10 2025-03-31 15712918 d:OwnedOrFreeholdAssets 2024-05-10 2025-03-31 15712918 d:CurrentFinancialInstruments 2025-03-31 15712918 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 15712918 d:ShareCapital 2025-03-31 15712918 d:RetainedEarningsAccumulatedLosses 2025-03-31 15712918 c:OrdinaryShareClass1 2024-05-10 2025-03-31 15712918 c:OrdinaryShareClass1 2025-03-31 15712918 c:OrdinaryShareClass2 2024-05-10 2025-03-31 15712918 c:OrdinaryShareClass2 2025-03-31 15712918 c:OrdinaryShareClass3 2024-05-10 2025-03-31 15712918 c:OrdinaryShareClass3 2025-03-31 15712918 c:FRS102 2024-05-10 2025-03-31 15712918 c:AuditExempt-NoAccountantsReport 2024-05-10 2025-03-31 15712918 c:FullAccounts 2024-05-10 2025-03-31 15712918 c:PrivateLimitedCompanyLtd 2024-05-10 2025-03-31 15712918 e:PoundSterling 2024-05-10 2025-03-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 15712918 HERTS-LONDON CARDIOLOGY LTD UNAUDITED FINANCIAL STATEMENTS INFORMATION FOR FILING WITH THE REGISTRAR FOR THE PERIOD ENDED 31 MARCH 2025
HERTS-LONDON CARDIOLOGY LTD REGISTERED NUMBER: 15712918 BALANCE SHEET AS AT 31 MARCH 2025
|  | 2025
Note |  | £
Fixed assets |  |  |
Tangible assets | 4 |  | 44,630
Current assets |  |  |
Debtors: amounts falling due within one year | 5 | 261,442 |
Cash at bank and in hand | 6 | 5,356 |
|  | 266,798 |
Creditors: amounts falling due within one year | 7 | (75,887) |
Net current assets |  |  | 190,911
Net assets |  |  | 235,541
Capital and reserves |  |  |
Called up share capital | 8 |  | 100
Profit and loss account |  |  | 235,441
|  |  | 235,541
The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements. The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities. The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime. The financial statements were approved and authorised for issue by the board and were signed on its behalf by:
P Kirk
Director
Date: 5 February 2026
The notes on pages 2 to 6 form part of these financial statements. Page 1
HERTS-LONDON CARDIOLOGY LTD NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 MARCH 2025
1. | General information
Herts-London Cardiology Limited is a private company, limited by shares, domiciled in England and Wales, registration number 15712918. The registered office address is 91 Mount View Road, London, N4 4JA. The Company was incorporated on 10 May 2024 and the financial statements are prepared for the period from 10 May 2024 to 31 March 2025. The principal activities of the Company are specialist medical practice activities. 2.Accounting policies
| 2.1 | Basis of preparation of financial statements
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the requirements and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view. The financial statements are presented in £ sterling, the functional currency, rounded to the nearest £1. The following principal accounting policies have been applied:
| 2.2 | Revenue
Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised: Rendering of services Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied: ∙the amount of revenue can be measured reliably; ∙it is probable that the Company will receive the consideration due under the contract; ∙the stage of completion of the contract at the end of the reporting period can be measured reliably; and ∙the costs incurred and the costs to complete the contract can be measured reliably. Page 2
HERTS-LONDON CARDIOLOGY LTD NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 MARCH 2025 2.Accounting policies (continued)
| 2.3 | Taxation
Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively. The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.
| 2.4 | Tangible fixed assets
Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management. Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method. Depreciation is provided on the following basis:
|  |  |  | Motor vehicles | - | 25%
|  |  |  | Office equipment | - | 25%
|  |  |  | Computer equipment | - | 25%
The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date. Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.
| 2.5 | Debtors
Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.
| 2.6 | Cash and cash equivalents
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.
| 2.7 | Creditors
Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method. Page 3
HERTS-LONDON CARDIOLOGY LTD NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 MARCH 2025 2.Accounting policies (continued)
| 2.8 | Financial instruments
The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments. Financial instruments are recognised in the Company's Balance Sheet when the Company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. Basic financial assets Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments. Basic financial liabilities Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities. Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial. Debt instruments are subsequently carried at their amortised cost using the effective interest rate method. Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.
| 2.9 | Dividends
Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting. Page 4
HERTS-LONDON CARDIOLOGY LTD NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 MARCH 2025
3. | Employees
| The average monthly number of employees, including directors, during the period was 2.
4. | Tangible fixed assets
|  | Motor vehicles | Office equipment | Computer equipment | Total
|  | £ | £ | £ | £
| Cost or valuation |  |  |  |
| Additions | 54,080 | 548 | 1,438 | 56,066
| At 31 March 2025 | 54,080 | 548 | 1,438 | 56,066
| Depreciation |  |  |  |
| Charge for the period | 11,267 | 49 | 120 | 11,436
| At 31 March 2025 | 11,267 | 49 | 120 | 11,436
| Net book value |  |  |  |
| At 31 March 2025 | 42,813 | 499 | 1,318 | 44,630
5. | Debtors
|  |  |  |  | 2025
|  |  |  |  | £
| Other debtors | 256,079
| Prepayments and accrued income | 5,363
|  | 261,442
6. | Cash and cash equivalents
|  |  |  |  | 2025
|  |  |  |  | £
| Cash at bank and in hand | 5,356
Page 5
HERTS-LONDON CARDIOLOGY LTD NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 MARCH 2025
7. | Creditors: Amounts falling due within one year
|  |  |  |  | 2025
|  |  |  |  | £
| Corporation tax | 72,974
| Other creditors | 413
| Accruals | 2,500
|  | 75,887
8. | Share capital
|  |  |  |  | 2025
|  |  |  |  | £
|  | Allotted, called up and fully paid |
|  | 50 Ordinary A shares of £1.00 each | 50
|  | 40 Ordinary B shares of £1.00 each | 40
|  | 10 Ordinary C shares of £1.00 each | 10
|  |  | 100
During the period, 50 Ordinary A, 40 Ordinary B and 10 Ordinary C Shares of £1 each were issued, allotted and fully paid.
Page 6